0001209191-13-037027.txt : 20130717 0001209191-13-037027.hdr.sgml : 20130717 20130717164649 ACCESSION NUMBER: 0001209191-13-037027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130716 FILED AS OF DATE: 20130717 DATE AS OF CHANGE: 20130717 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDASSETS INC CENTRAL INDEX KEY: 0001254419 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 510391128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 BUSINESS PHONE: 6783232500 MAIL ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BALLARD RAND A CENTRAL INDEX KEY: 0001415811 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33881 FILM NUMBER: 13972986 MAIL ADDRESS: STREET 1: 100 NORTH POINT CENTER EAST STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30022 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-07-16 0 0001254419 MEDASSETS INC MDAS 0001415811 BALLARD RAND A 100 NORTH POINT CENTER EAST SUITE 200 ALPHARETTA GA 30022 1 1 0 0 Chief Customer Officer Common Stock 2013-07-16 4 M 0 15082 15.95 A 85787 D Common Stock 2013-07-16 4 S 0 13163 20.00 D 72624 D Common Stock 2013-07-16 4 M 0 11618 0.00 A 84242 D Restricted Stock 12920 D Restricted Stock 19380 D Restricted Stock 19380 D Stock Options (Right to Buy) 15.95 2013-07-16 4 M 0 15082 0.00 D 2018-03-25 Common Stock 15082 0 D Stock-Settled Stock Appreciation Rights 14.74 2013-07-16 4 M 0 66124 0.00 D 2016-01-05 Common Stock 66124 22042 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2012. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.03, inclusive. The reporting person undertakes to provide to MedAssets, Inc., any security holder of MedAssets, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range noted. The reporting person was granted these service-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016. The reporting person was granted these performance-based restricted shares on February 25, 2013. The shares vest approximately 33.3% on each of March 1, 2014, 2015 and 2016 based on the achievement of certain Company financial performance targets for fiscal year 2013. The reporting person was granted these stock options on March 25, 2008 and are fully vested. The reporting person was granted these stock-settled stock appreciation rights (SSARs) on January 5, 2009 and are fully vested. /s/ Christopher K. Logsdon, Attorney-In-Fact 2013-07-17